Our mission is to provide powerful tools that translate what is happening in a patients’ body into a readable and interpretable language.

We call it our new language of life. 

The “language of life” makes it easier to understand, diagnose and treat chronic and metabolic diseases produced by the modern way of life. Cancer, obesity, aging and depression share a common biology: they are metabolic and inflammatory. Those pathological imbalances lead to protein modification which require special separation techniques to give us a better understanding. Capillary Electrophoresis (CE) is the most accurate and efficient method of separation to unlock these complex conditions.

Sebia is a Global specialized In Vitro Diagnostic player and the world’s leading provider of clinical protein electrophoresis equipment and reagents for the screening and monitoring of various diseases, primarily in the areas of Oncology (Multiple Myeloma), Diabetes, Hemoglobinopathy and other rare pathologies.

Headquartered in the South of Paris (Lisses, France), We set high standards in making continuous advances in CE technology, scientific excellence and manufacturing capabilities, providing Sebia the possibility to pursue diagnostic solutions with an exciting pipeline of new tests and automated equipment.

Biotechnology

Health Care

Health Diagnostics

Life Sciences

Medical Devices

Sebia

Ollie Mitchell

Laurence Rouet

Thomas Lohmann

Vincent Verfaillie

Karen Anderson

Rodolphe Chabannaud

Cyrille Schreider

Claude Anguille

Arnaud Collin

Shigehide Onoda

Zhigang Wan

Leadership Team

Commercial Operations

Marketing Team

Teams at Sebia

Leadership Team

Commercial Operations

Marketing Team